Why Advanced Biomed Inc.’s (ADVB) Stock Is Down 7.93%
As of Tuesday, April 08, Advanced Biomed Inc.’s ADVB share price has dipped by 7.93%, which has investors questioning if this is right time to buy.Jenna Brashear
Stock Evaluator: Advanced Biomed Inc. (ADVB)
Advanced Biomed Inc. ADVB
$2.73
-0.44
-13.88%
October 26, 2026 3:51:40 PM
EST
Volume: 14,704
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. It offers A+Pre, a device that prepares blood samples for testing; the AC-1000, a device that separates cancer cells from the rest of the blood; A+SCDrop, a device that isolates individual cells; and A+CellScan, a device that stains and automatically counts cancer cells. The company provides developed dye kits used to identify different types of cancer cells. It also offers FinTruth financial verification agent platform, an enterprise AI financial verification platform designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, and to produce source-traceable and auditable results. The company was founded in 2014 and is based in Tsuen Wan, Hong Kong.
Commentary & Analysis
Why Advanced Biomed Inc.’s (ADVB) Stock Is Down 7.24%
As of Tuesday, April 08, Advanced Biomed Inc.’s ADVB share price has dipped by 7.24%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Advanced Biomed Inc.’s (ADVB) Stock Is Down 13.79%
As of Tuesday, April 08, Advanced Biomed Inc.’s ADVB share price has dipped by 13.79%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Advanced Biomed Inc.’s (ADVB) Stock Is Down 25.17%
As of Tuesday, April 08, Advanced Biomed Inc.’s ADVB share price has dipped by 25.17%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | ADVB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4.5 | $403.5 | 4% |
|
| Shares Out (Mil) | 1.6 | 40.7 | 6% |
|
| Institutional Ownership | 0.1% | 83.3% | 1% |
|
| Float (Mil) | 0.7 | 34.5 | 2% |
|
| Beta | na | 0.85 | na |
|
| Avg Daily Volume (000s) | 56 | 272 | 30% |
|
| Price Change (52-week) |
(69.0%) | 63.7% | 12% |
|
| Growth | ADVB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | 41.7% | (5.5%) | 91% |
|
| EPS (5yr) | 29.6% | 10.7% | 81 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ADVB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $141 | 0% |
|
| Net Income (TTM) (Mil) | $7 | ($9) | 44% |
|
| EPS (TTM) | $5.330 | ($0.400) | 87% |
|
| Operating Cash Flow (TTM) (Mil) | ($2) | ($2) | 29% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $27 | 0% |
|
| Enterprise Value (Q1) (Mil) | $7 | $418 | 7% |
|
| Valuation | ADVB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.37 | 2.50 | 7% |
|
| P/E | na | 27.4 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | ADVB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 100.0% | 59.3% | 96% |
|
| Net Margin | na | (6.9%) | na |
|
| ROA | 36.5% | (12.2%) | 99% |
|
| ROE | 84.8% | (10.7%) | 96% |
|
| Liabilities to Assets | 10.7% | 47.2% | 6% |
|
| F-Score | 4 | 4 | 34% |
|
Advanced Biomed Inc. did not pass any screens on 10/26/2026.
